scispace - formally typeset
T

Thomas N. Walsh

Researcher at Royal College of Surgeons in Ireland

Publications -  139
Citations -  5011

Thomas N. Walsh is an academic researcher from Royal College of Surgeons in Ireland. The author has contributed to research in topics: Chemoradiotherapy & Cancer. The author has an hindex of 31, co-authored 127 publications receiving 4735 citations. Previous affiliations of Thomas N. Walsh include Trinity College, Dublin & Mater Misericordiae Hospital.

Papers
More filters
Journal ArticleDOI

Virtual outpatient clinic as an alternative to an actual clinic visit after surgical discharge: a randomised controlled trial.

TL;DR: The majority of patients discharged from a surgical service could be better followed up by a virtual clinic with a significant proportion of patients reporting a preference for and a greater satisfaction with such a service.
Journal ArticleDOI

Cholecystectomy and oesophageal reflux: a prospective evaluation.

TL;DR: The data suggest that cholecystectomy results in gastro‐oesophageal reflux that appears to be related to compromised sphincter competence.
Journal ArticleDOI

REVIEWS — Tumour micrometastases: the influence of angiogenesis

TL;DR: There is increasing evidence that micrometastatic status provides useful prognostic information and should be part of standard staging techniques, and anti-angiogenic therapy has the potential to favourably influence management of certain cancers by manipulating a number of key events in the metastatic process.
Journal ArticleDOI

Prevalence of bone marrow micrometastases in esophagogastric cancer patients with and without neoadjuvant chemoradiotherapy.

TL;DR: A significant proportion of patients with esophagogastric cancer have disseminated viable tumor cells at time of surgery, irrespective of pre-operative treatment, and the use of marrow culture in parallel with fresh marrow staining may increase the detection of micrometastases.
Journal ArticleDOI

Effect of multimodality therapy on circulating vascular endothelial growth factor levels in patients with oesophageal cancer.

TL;DR: In this article, the authors found that patients with oesophageal cancer would express raised serum levels of vascular endothelial growth factor (VEGF) which would return to normal values with neoadjuvant chemoradiotherapy.